Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Goodwill (2023 - 2025)

Indivior Pharmaceuticals has reported Goodwill over the past 3 years, most recently at $2.0 million for Q4 2025.

  • Quarterly results put Goodwill at $2.0 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $2.0 million (changed 0.0% YoY), and the annual figure for FY2025 was $2.0 million, changed 0.0%.
  • Goodwill for Q4 2025 was $2.0 million at Indivior Pharmaceuticals, roughly flat from $2.0 million in the prior quarter.
  • Over the last five years, Goodwill for INDV hit a ceiling of $5.0 million in Q4 2023 and a floor of $2.0 million in Q1 2024.
  • Median Goodwill over the past 3 years was $2.0 million (2024), compared with a mean of $2.8 million.
  • Biggest five-year swings in Goodwill: plummeted 60.0% in 2024 and later changed 0.0% in 2025.
  • Indivior Pharmaceuticals' Goodwill stood at $5.0 million in 2023, then plummeted by 60.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
  • The last three reported values for Goodwill were $2.0 million (Q4 2025), $2.0 million (Q4 2024), and $2.0 million (Q1 2024) per Business Quant data.